Matches in SemOpenAlex for { <https://semopenalex.org/work/W2945574845> ?p ?o ?g. }
- W2945574845 endingPage "1824" @default.
- W2945574845 startingPage "1818" @default.
- W2945574845 abstract "Although allogeneic hematopoietic stem cell transplantation (allo-HSCT) can be associated with neurologic complications, data on noninfectious etiologies are scanty. Therefore, we analyzed the incidence, clinical characteristics, risk factors, and influence on outcomes of noninfectious neurologic complications (NCs) in 971 consecutive patients with hematologic malignancies undergoing allo-HSCT at our center between January 2000 and December 2016. We evaluated NCs affecting the central nervous system (CNS) and peripheral nervous system (PNS). The median duration of follow-up of survivors was 71 months (range, 11 to 213 months). A total of 467 patients received a matched sibling donor (MSD) transplant, 381 received umbilical cord blood (UCB), 74 received a haploidentical transplant, and 49 received a matched unrelated donor (MUD) transplant. One hundred forty-nine (15.3%) NCs were documented at a median of 78 days after transplantation (range, 5 days before to 3722 days after). The cumulative incidence risk of developing NC was 7.5% (95% confidence interval, 6% to 8.2%) at day +90 and 13% at 5 years. The 5-year cumulative incidence of NCs was 10.8% after MSD allo-HSCT and 15.3% after alternative donor (UCB, MUD, haploidentical) allo-HSCT (P = .004). There were 101 (68%) CNS complications, including encephalopathy, n = 46 (31%); headache, n = 20 (13%); stroke, n = 15 (10%); seizures, n = 9 (6%), posterior reversible encephalopathy syndrome, n = 6 (4%), and myelopathy, n = 5 (3%). PNS complications (32%) included neuropathies, n = 25 (17%), and myopathies and neuromuscular junction disorders, n = 23 (17%), with 17% of the total PNS complications being immune-related. In multivariable analysis, donor type other than MSD, age ≥40 years, development of acute graft-versus-host disease (GVHD) grade II-IV (hazard ratio [HR], 3.3; P < .00001), and extensive chronic GVHD (HR, 3.2; P = .0002) were independently associated with increased risk of NCs. The 5-year overall survival (OS) was 21% in patients who developed NCs and 41% for those who did not (P < .0001). This difference in OS was observed in patients developing CNS NCs, but not in those developing PNS complications. In conclusion, our study reveals NCs as a frequent and heterogeneous complication that, when affecting CNS, is associated with poor prognosis following allo-HSCT." @default.
- W2945574845 created "2019-05-29" @default.
- W2945574845 creator A5005476543 @default.
- W2945574845 creator A5009665482 @default.
- W2945574845 creator A5010159667 @default.
- W2945574845 creator A5017341923 @default.
- W2945574845 creator A5023395909 @default.
- W2945574845 creator A5037815083 @default.
- W2945574845 creator A5040307230 @default.
- W2945574845 creator A5045558241 @default.
- W2945574845 creator A5052934298 @default.
- W2945574845 creator A5053938175 @default.
- W2945574845 creator A5054250233 @default.
- W2945574845 creator A5063018703 @default.
- W2945574845 creator A5063076351 @default.
- W2945574845 creator A5065813746 @default.
- W2945574845 creator A5067166918 @default.
- W2945574845 creator A5074617820 @default.
- W2945574845 creator A5077525322 @default.
- W2945574845 date "2019-09-01" @default.
- W2945574845 modified "2023-10-18" @default.
- W2945574845 title "Noninfectious Neurologic Complications after Allogeneic Hematopoietic Stem Cell Transplantation" @default.
- W2945574845 cites W1935154669 @default.
- W2945574845 cites W1966738818 @default.
- W2945574845 cites W1972290531 @default.
- W2945574845 cites W1977092248 @default.
- W2945574845 cites W1979414324 @default.
- W2945574845 cites W1989571276 @default.
- W2945574845 cites W1989822076 @default.
- W2945574845 cites W1993584540 @default.
- W2945574845 cites W2002235348 @default.
- W2945574845 cites W2002706596 @default.
- W2945574845 cites W2004040420 @default.
- W2945574845 cites W2007288055 @default.
- W2945574845 cites W2010256720 @default.
- W2945574845 cites W2038981426 @default.
- W2945574845 cites W2060845813 @default.
- W2945574845 cites W2061473590 @default.
- W2945574845 cites W2073140442 @default.
- W2945574845 cites W2074686004 @default.
- W2945574845 cites W2092116640 @default.
- W2945574845 cites W2095961994 @default.
- W2945574845 cites W2101134081 @default.
- W2945574845 cites W2108928169 @default.
- W2945574845 cites W2116756714 @default.
- W2945574845 cites W2122976852 @default.
- W2945574845 cites W2148070164 @default.
- W2945574845 cites W2158434463 @default.
- W2945574845 cites W2163296163 @default.
- W2945574845 cites W2326297993 @default.
- W2945574845 cites W2327451975 @default.
- W2945574845 cites W2330461684 @default.
- W2945574845 cites W2542527167 @default.
- W2945574845 cites W2552117617 @default.
- W2945574845 cites W2560980055 @default.
- W2945574845 cites W2769339849 @default.
- W2945574845 cites W2782130485 @default.
- W2945574845 cites W4293241248 @default.
- W2945574845 doi "https://doi.org/10.1016/j.bbmt.2019.05.024" @default.
- W2945574845 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31132454" @default.
- W2945574845 hasPublicationYear "2019" @default.
- W2945574845 type Work @default.
- W2945574845 sameAs 2945574845 @default.
- W2945574845 citedByCount "27" @default.
- W2945574845 countsByYear W29455748452019 @default.
- W2945574845 countsByYear W29455748452020 @default.
- W2945574845 countsByYear W29455748452021 @default.
- W2945574845 countsByYear W29455748452022 @default.
- W2945574845 countsByYear W29455748452023 @default.
- W2945574845 crossrefType "journal-article" @default.
- W2945574845 hasAuthorship W2945574845A5005476543 @default.
- W2945574845 hasAuthorship W2945574845A5009665482 @default.
- W2945574845 hasAuthorship W2945574845A5010159667 @default.
- W2945574845 hasAuthorship W2945574845A5017341923 @default.
- W2945574845 hasAuthorship W2945574845A5023395909 @default.
- W2945574845 hasAuthorship W2945574845A5037815083 @default.
- W2945574845 hasAuthorship W2945574845A5040307230 @default.
- W2945574845 hasAuthorship W2945574845A5045558241 @default.
- W2945574845 hasAuthorship W2945574845A5052934298 @default.
- W2945574845 hasAuthorship W2945574845A5053938175 @default.
- W2945574845 hasAuthorship W2945574845A5054250233 @default.
- W2945574845 hasAuthorship W2945574845A5063018703 @default.
- W2945574845 hasAuthorship W2945574845A5063076351 @default.
- W2945574845 hasAuthorship W2945574845A5065813746 @default.
- W2945574845 hasAuthorship W2945574845A5067166918 @default.
- W2945574845 hasAuthorship W2945574845A5074617820 @default.
- W2945574845 hasAuthorship W2945574845A5077525322 @default.
- W2945574845 hasBestOaLocation W29455748451 @default.
- W2945574845 hasConcept C120665830 @default.
- W2945574845 hasConcept C121332964 @default.
- W2945574845 hasConcept C126322002 @default.
- W2945574845 hasConcept C126838900 @default.
- W2945574845 hasConcept C127413603 @default.
- W2945574845 hasConcept C137627325 @default.
- W2945574845 hasConcept C141071460 @default.
- W2945574845 hasConcept C143409427 @default.
- W2945574845 hasConcept C203014093 @default.
- W2945574845 hasConcept C2776955114 @default.